Add like
Add dislike
Add to saved papers

Degradation of levofloxacin using electro coagulation residuals-alginate beads as a novel heterogeneous electro-fenton composite.

The presence of levofloxacin (LEV) in aqueous solutions can pose health risks to humans, have adverse effects on aquatic organisms and ecosystems, and contribute to the development of antibiotic-resistant bacteria. This study aims to investigate the feasibility of using electrocoagulation residuals (ECRs) as a heterogeneous catalyst in the electro-Fenton process for degrading LEV. By combining electrocoagulation residuals with sodium alginate, ECRs-alginate beads were synthesized as a heterogeneous electro-Fenton composite. The response surface method was employed to investigate the optimization and influence of various operating parameters such as the initial concentration of LEV (10-50 mg/L), voltage (15-35 V), pH (3-9), and catalyst dose (1-9 g/L). The successful incorporation of iron and other metals into the ECRs-alginate beads was confirmed by characterization tests such as EDX and FTIR. By conducting a batch reaction under optimal conditions (initial LEV concentration = 20 mg/L, pH = 4.5, voltage = 30V, and catalyst dose = 7 g/L), a remarkable degradation of 99% for LEV was achieved. Additionally, under these optimal conditions, a high removal efficiency of 92.3% for total organic carbon (TOC) could be attained within 120 min and these findings are remarkable compared to previous studies. The results further indicated that the degradation of levofloxacin (LEV) could be accurately quantified by utilizing the first-order kinetic reaction with a 0.03 min-1 rate constant. The synthesized beads offered notable advantages in terms of being eco-friendly, simple to use, highly efficient, and easily recoverable from the liquid medium after use.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app